During the 2010 ACR/ARHP Annual Scientific Meeting, the ACR and others used Twitter to enhance the annual meeting experience, make connections with one another, and share information. There were approximately 600 tweets from 150 contributors during the meeting. Here’s a sample of what people were saying:
@JointMD Great talk this morning by Stacey Empson on HIT [health information technology] and the ARRA [American Recovery and Reinvestment Act] legislation. Check it out on SessionSelect. #ACR2010
@Laccheo Great lecture on labs even for us clinicians by Dr. Wener. #ACR2010
@SENGLAITAN Learning about the role of autophagy in RA [rheumatoid arthritis] & potential therapeutic targets #ACR2010
@NuclearFire Alternative “medicine” has no place in rheumatology. Either prove something works or don’t use it, just like with normal pharm. #ACR2010
@LupusOrg Speaker from Netherlands says goals of healthcare providers: help patients, restore health (incl. QOL [quality of life]) & treat disease. #ACR2010
@SjogrensCEO Sjogren’s Study Group session at ACR was well attended! Very exciting to see so many clinicians/researchers wanting to know more.
@Sunkureddi #ACR2010 Very good lectures on osteoporosis. Useful and practical information especially on navigating FRAX
@ElkhaliliMD #ACR2010 no added risk of malignancy with anti-TNF [tumor necrosis factor] exposure, large study at the meeting shows but needs follow up
@carvicab Latin American group focus on genetic of autoimmune disease that is great issue in this countries because the mixture of races #acr2010
@doctorsrheum Fave talk so far MTP session w/Clowse from Duke on pregnancy mgmt in rheum pts. Great take-home points! #ACR2010
The ACR uses Twitter to share other information about the its work, such as promoting the release of ACR’s recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis, as well as to encourage action on issues, such as asking individuals to contact Congress regarding SGR cuts. We also use it to share information from other organizations or news sources, answer questions from members and others interested in rheumatology, and listen to the conversations affecting the profession and practice of rheumatology. Follow us at www.twitter.com/ACRheum.